COMMENTARY

• With 1/4 of Pharma Backers Losing Seats, It’s Time for Industry to Revamp Lobbying Activities
  November 11, 2024

• Survey Hints LLP New Coverage Rule Could Push Generic Switches for Cancer Drugs, Pediatric Meds
  October 8, 2024

• LLP Info Might Become Inaccessible If New Coverage Rule Speeds Up Exit
  September 10, 2024

• Japan’s Drug-Loss Landscape Is Transforming Driven by Private Sector
  August 21, 2024

• How Will Simplified Delisting, Elective Care Affect G1 Withdrawal Scheme?
  August 7, 2024

• Analysis: All Eyes Riveted on FY2024 Drug Price Survey for Off-Year Revision
  August 6, 2024

• Lively Debate on Generic Industry Revamp Underway, All Eyes on Consortium Model
  July 12, 2024

• Industry’s Ability to Communicate Being Put to Test as Views on Off-Year Price Cuts Change
  June 11, 2024

• With Only 5 Months Until Nitrosamine Self-Inspection Deadline, Many Challenges Remain
  June 7, 2024

• Japan Employees Shaken by Teva’s Divestment Plan, Soft Landing Wanted on Supply Front
  June 4, 2024

• Can Japan Generic Industry Accelerate Self-Reform? MHLW Panel Debate Now in Homestretch
  April 19, 2024

• With Honebuto 2024 Looming, Now Is the Time to Revisit Social Security Spending
  April 2, 2024

• With So Many of Its Demands Met, How Will Industry Oppose Off-Year Price Revisions in FY2025?
  March 12, 2024

• Is Case of Leqembi a “Steppingstone” to New CEA Price Adjustment Rule? Pharma Industry on Guard
  January 30, 2024

• Goals of the “Innovation Box” Tax Break in FY2024 Reform
  January 23, 2024

• Introduction of Elective Care to Mark Watershed for Long-Listed Drug Makers
  January 17, 2024

• Change of Tide in Reform: Lopsided Cost Cuts to Balanced Pro-Innovation Policy
  December 27, 2023

• Key Figures in Next Drug Pricing Reform Now All in Place, In What Direction Will They Go for Pro-Innovation Drive?
  November 15, 2023

• Predicting Clinical, Financial Impact of Hemophilia Gene Therapy in Japan
  November 7, 2023

• Reform Proposal Signals Perception Gap between Industry, Govt on Purpose of Market Expansion Re-Pricing
  October 31, 2023

ページ